1. Home
  2. CHH vs PTCT Comparison

CHH vs PTCT Comparison

Compare CHH & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Choice Hotels International Inc.

CHH

Choice Hotels International Inc.

HOLD

Current Price

$115.01

Market Cap

5.1B

ML Signal

HOLD

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$78.88

Market Cap

5.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHH
PTCT
Founded
1939
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1B
5.7B
IPO Year
1997
2006

Fundamental Metrics

Financial Performance
Metric
CHH
PTCT
Price
$115.01
$78.88
Analyst Decision
Hold
Buy
Analyst Count
11
17
Target Price
$114.30
$80.65
AVG Volume (30 Days)
626.2K
1.5M
Earning Date
04-30-2026
05-07-2026
Dividend Yield
0.98%
N/A
EPS Growth
27.42
264.48
EPS
0.44
N/A
Revenue
$1,596,793,000.00
$264,734,000.00
Revenue This Year
$66.74
N/A
Revenue Next Year
$0.37
$17.70
P/E Ratio
$261.02
N/A
Revenue Growth
0.75
36.19
52 Week Low
$84.04
$43.18
52 Week High
$136.45
$87.50

Technical Indicators

Market Signals
Indicator
CHH
PTCT
Relative Strength Index (RSI) 57.25 63.72
Support Level $102.06 $73.41
Resistance Level $116.89 $79.67
Average True Range (ATR) 4.30 3.08
MACD 0.70 0.69
Stochastic Oscillator 80.87 91.83

Price Performance

Historical Comparison
CHH
PTCT

About CHH Choice Hotels International Inc.

At year-end 2025, Choice Hotels operated 657,000 rooms across the economy, midscale, upscale, and extended-stay segments. Comfort Inn and Comfort Suites are the largest brands (27% of the company's total rooms), while Ascend and Cambria (10%) are lifestyle and select-service brands, and WoodSpring (5%) is the company's largest extended-stay brand. Choice closed on its Radisson acquisition in August 2022, which added about 70,000 rooms. Franchises account for 100% of total revenue, and the United States represented 78% of total rooms in 2025.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

Share on Social Networks: